![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Ofichem Header](https://www.pharmacompass.com/image/flap/ofichem-corp-ad-w31-desktop-headergif-65408.gif)
![Ofichem Header](https://www.pharmacompass.com/image/flap/ofichem-corp-ad-w31-mobile-headergif-45399.gif)
X
20
Zhejiang Zhebei Pharmaceutical Co., Ltd Xinshi Town, Deqing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Aciclovir, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-077 - Rev 00
This Chemical Type CEP, issued on February 19, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 968 associated with this CEP further emphasizes